![](/img/cover-not-exists.png)
PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER
Bonthapally, V., Suthoff, E., Hodgkins, P., Gunduz-Bruce, H., Lasser, R., Silber, C., Sankoh, A., Li, H., Jonas, J., Doherty, J., Kanes, S.Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.2887
Date:
October, 2018
File:
PDF, 308 KB
english, 2018